Healthcare provider profile · identity verified

Karmina Bautista, MD

Internal Medicine · N DARTMOUTH, MA · NPI 1033131008

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	657	147
Pravastatin Sodium	Pravastatin Sodium	460	125
Omeprazole	Omeprazole	429	100
Atorvastatin Calcium	Atorvastatin Calcium	375	91
Lisinopril	Lisinopril	350	87
Losartan Potassium	Losartan Potassium	329	79
Levothyroxine Sodium	Levothyroxine Sodium	307	62
Albuterol Sulfate Hfa	Albuterol Sulfate	260	79
Hydrochlorothiazide	Hydrochlorothiazide	258	73
Metoprolol Succinate	Metoprolol Succinate	252	62
Pantoprazole Sodium	Pantoprazole Sodium	225	41
Gabapentin	Gabapentin	223	40
Lorazepam	Lorazepam	219	38
Metformin Hcl	Metformin Hcl	199	54
Trazodone Hcl	Trazodone Hcl	181	42
Simvastatin	Simvastatin	177	44
Alprazolam	Alprazolam	153	28
Furosemide	Furosemide	148	36
Rosuvastatin Calcium	Rosuvastatin Calcium	140	39
Clonazepam	Clonazepam	125	16
Fluticasone Propionate	Fluticasone Propionate	108	36
Meloxicam	Meloxicam	105	22
Oxycodone Hcl	Oxycodone Hcl	104	12
Ibuprofen	Ibuprofen	100	28
Alendronate Sodium	Alendronate Sodium	99	17
Triamcinolone Acetonide	Triamcinolone Acetonide	93	46
Ventolin Hfa	Albuterol Sulfate	93	25
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	92	11
Tizanidine Hcl	Tizanidine Hcl	84	24
Ezetimibe	Ezetimibe	83	22
Fluconazole	Fluconazole	83	20
Famotidine	Famotidine	81	21
Fluoxetine Hcl	Fluoxetine Hcl	80	15
Zolpidem Tartrate	Zolpidem Tartrate	80	suppressed
Eliquis	Apixaban	79	18
Potassium Chloride	Potassium Chloride	74	19
Metoprolol Tartrate	Metoprolol Tartrate	71	20
Tramadol Hcl	Tramadol Hcl	71	16
Citalopram Hbr	Citalopram Hydrobromide	69	14
Escitalopram Oxalate	Escitalopram Oxalate	68	15
Clopidogrel	Clopidogrel Bisulfate	67	14
Hydralazine Hcl	Hydralazine Hcl	64	15
Ketoconazole	Ketoconazole	63	31
Sertraline Hcl	Sertraline Hcl	58	13
Bupropion Hcl Sr	Bupropion Hcl	57	15
Prednisone	Prednisone	56	34
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	54	15
Allopurinol	Allopurinol	53	12
Doxycycline Hyclate	Doxycycline Hyclate	53	50
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Glipizide	Glipizide	51	16
Valacyclovir	Valacyclovir Hcl	51	20
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	49	suppressed
Lovastatin	Lovastatin	49	13
Ondansetron Hcl	Ondansetron Hcl	49	suppressed
Nystatin	Nystatin	46	16
Repaglinide	Repaglinide	44	11
Diclofenac Sodium	Diclofenac Sodium	41	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Synthroid	Levothyroxine Sodium	40	suppressed
Atenolol	Atenolol	39	suppressed
Ozempic	Semaglutide	38	suppressed
Mirtazapine	Mirtazapine	37	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	36	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	36	suppressed
Symbicort	Budesonide/Formoterol Fumarate	36	11
Breo Ellipta	Fluticasone/Vilanterol	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	28
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Chlorthalidone	Chlorthalidone	31	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Lactulose	Lactulose	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Nyamyc	Nystatin	28	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	28	suppressed
Carvedilol	Carvedilol	24	suppressed
Dulera	Mometasone/Formoterol	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	12
Azithromycin	Azithromycin	23	15
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Clotrimazole	Clotrimazole	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Colestipol Hcl	Colestipol Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Torsemide	Torsemide	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Mupirocin	Mupirocin	19	16
Ondansetron Odt	Ondansetron	19	suppressed
Valsartan	Valsartan	19	suppressed
Amoxicillin	Amoxicillin	18	11
Carisoprodol	Carisoprodol	18	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	18	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	15
Clobetasol Propionate	Clobetasol Propionate	15	11
Naproxen	Naproxen	15	suppressed
Constulose	Lactulose	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Nystop	Nystatin	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Spiriva Handihaler	Tiotropium Bromide	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Diazepam	Diazepam	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Linzess	Linaclotide	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Erythromycin	Erythromycin Base	12	12
Glipizide Er	Glipizide	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	11
Prochlorperazine Maleate	Prochlorperazine Maleate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Calcitriol	Calcitriol	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Methadone Hcl	Methadone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error